182 related articles for article (PubMed ID: 36618714)
1. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid.
Fessel J
Discov Ment Health; 2023; 3(1):1. PubMed ID: 36618714
[TBL] [Abstract][Full Text] [Related]
2. Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.
Fessel J
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902833
[TBL] [Abstract][Full Text] [Related]
3. Case Reports: Exposure to SARS-CoV-2, Acute Kidney Injury, and Lithium Toxicity.
McInnis MG; Yocum AK
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):461-463. PubMed ID: 35916582
[TBL] [Abstract][Full Text] [Related]
4. Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD).
Fessel J
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836215
[TBL] [Abstract][Full Text] [Related]
5. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
[TBL] [Abstract][Full Text] [Related]
6. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
Crunfli F; Carregari VC; Veras FP; Silva LS; Nogueira MH; Antunes ASLM; Vendramini PH; Valença AGF; Brandão-Teles C; Zuccoli GDS; Reis-de-Oliveira G; Silva-Costa LC; Saia-Cereda VM; Smith BJ; Codo AC; de Souza GF; Muraro SP; Parise PL; Toledo-Teixeira DA; Santos de Castro ÍM; Melo BM; Almeida GM; Firmino EMS; Paiva IM; Silva BMS; Guimarães RM; Mendes ND; Ludwig RL; Ruiz GP; Knittel TL; Davanzo GG; Gerhardt JA; Rodrigues PB; Forato J; Amorim MR; Brunetti NS; Martini MC; Benatti MN; Batah SS; Siyuan L; João RB; Aventurato ÍK; Rabelo de Brito M; Mendes MJ; da Costa BA; Alvim MKM; da Silva Júnior JR; Damião LL; de Sousa IMP; da Rocha ED; Gonçalves SM; Lopes da Silva LH; Bettini V; Campos BM; Ludwig G; Tavares LA; Pontelli MC; Viana RMM; Martins RB; Vieira AS; Alves-Filho JC; Arruda E; Podolsky-Gondim GG; Santos MV; Neder L; Damasio A; Rehen S; Vinolo MAR; Munhoz CD; Louzada-Junior P; Oliveira RD; Cunha FQ; Nakaya HI; Mauad T; Duarte-Neto AN; Ferraz da Silva LF; Dolhnikoff M; Saldiva PHN; Farias AS; Cendes F; Moraes-Vieira PMM; Fabro AT; Sebollela A; Proença-Modena JL; Yasuda CL; Mori MA; Cunha TM; Martins-de-Souza D
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2200960119. PubMed ID: 35951647
[TBL] [Abstract][Full Text] [Related]
7. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
[TBL] [Abstract][Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
9. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Schloer S; Brunotte L; Mecate-Zambrano A; Zheng S; Tang J; Ludwig S; Rescher U
Br J Pharmacol; 2021 Jun; 178(11):2339-2350. PubMed ID: 33825201
[TBL] [Abstract][Full Text] [Related]
10. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
11. Candidate Psychotropics against SARS - CoV - 2: A Narrative Review.
Khosravi M
Pharmacopsychiatry; 2022 Jan; 55(1):16-23. PubMed ID: 34399430
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day.
Eugene AR
F1000Res; 2021; 10():477. PubMed ID: 36262792
[No Abstract] [Full Text] [Related]
13. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
14. Italian intersociety consensus on management of long covid in children.
Esposito S; Principi N; Azzari C; Cardinale F; Di Mauro G; Galli L; Gattinara GC; Fainardi V; Guarino A; Lancella L; Licari A; Mancino E; Marseglia GL; Leonardi S; Nenna R; Zampogna S; Zona S; Staiano A; Midulla F
Ital J Pediatr; 2022 Mar; 48(1):42. PubMed ID: 35264214
[TBL] [Abstract][Full Text] [Related]
15. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.
Zulu JE; Banda D; Hines JZ; Luchembe M; Sivile S; Siwingwa M; Kampamba D; Zyambo KD; Chirwa R; Chirwa L; Malambo W; Barradas D; Sinyange N; Agolory S; Mulenga LB; Fwoloshi S
Pan Afr Med J; 2022; 41():26. PubMed ID: 35291364
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial.
Weng S; Tang J; Wang G; Wang X; Wang H
Curr Ther Res Clin Exp; 2007 Jul; 68(4):280-90. PubMed ID: 24683218
[TBL] [Abstract][Full Text] [Related]
17. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
[TBL] [Abstract][Full Text] [Related]
19. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
Schloer S; Brunotte L; Goretzko J; Mecate-Zambrano A; Korthals N; Gerke V; Ludwig S; Rescher U
Emerg Microbes Infect; 2020 Dec; 9(1):2245-2255. PubMed ID: 32975484
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients.
Spuch C; López-García M; Rivera-Baltanás T; Cabrera-Alvargonzález JJ; Gadh S; Rodrigues-Amorim D; Álvarez-Estévez T; Mora A; Iglesias-Martínez-Almeida M; Freiría-Martínez L; Pérez-Rodríguez M; Pérez-González A; López-Domínguez A; Longueira-Suarez MR; Sousa-Domínguez A; Araújo-Ameijeiras A; Mosquera-Rodríguez D; Crespo M; Vila-Fernández D; Regueiro B; Olivares JM
Front Pharmacol; 2022; 13():850583. PubMed ID: 35496309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
